Antioxidative effects of sesamin (a mixture of sesamin and episesamin) were evaluated in the liver, kidney and inferior vena cava of living rats using a radiofrequency ESR method. TEMPOL, 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl, was used as an in vivo redox probe, the half-life of which is believed to be correlated with the antioxidant status. The oral administration of sesamin (250 mg/kg rat weight) 3 h before ESR measurements shortened the half-life of TEMPOL in the liver by 10 -15% as compared with the controls, but did not affect the other organs. This effect was maintained for at least 3 h after the administration, and then disappeared at 24 h, corresponding to the results of our preliminary pharmacokinetic studies. Changes in the reducing ability were observed only in the hepatic sites of the sesamin-treated rats. These findings suggest that sesamin exhibits effective antioxidant activity in the liver via modulation of the intracellular redox status related to TEMPOL reduction. 
Introduction
Sesamin is one of the lignans found in sesame seeds and oil, and is partially epimerized to episesamin during the refining process of non-roasted sesame seed oil (Fig. 1) . 1 The multiple biological functions of sesamin and episesamin that have been previously reported include the inhibition of ∆5-desaturase, 2 antioxidant activities, [3] [4] [5] [6] [7] [8] and anti-inflammatory and antihypertensive effects. [8] [9] [10] Several studies have described the suppressive effects of sesamin on lipid peroxidation in vivo. [3] [4] [5] Yamashita et al. have also reported that sesamin enhanced the plasma and organ levels of alpha-and gamma-tocopherol in rats, which was perhaps due to the antioxidative activities of sesamin. 3, 4 The scavenging effects of sesamin and episesamin (sesamin:episesamin = 51.1:48.2, w/w) on superoxide anion radical (O2 • -) and hydroxyl radical (·OH) were very weak in vitro. 6, 11 A previous study that used an electron spin resonance (ESR) spin trapping assay found the O2 • -scavenging activity of a mixture of sesamin and episesamin (final concentration, 50 μM) was 3.0%, while the ·OH scavenging activity of the mixture (final concentration, 250 μM) was 2.3%. 11 On the other hand, Nakai et al. reported that sesamin was metabolized in the liver to (1R,2S,5R,6S)-6-(3,4-dihydroxyphenyl)-2-(3,4-methylenedioxyphenyl)-3,7-dioxabicyclo [3, 3, 0] octane (SC-1) and (1R,2S,5R,6S)-2,6-bis-(3,4-dihydroxyphenyl)-3,7-dioxabicyclo [3, 3, 0] octane (SC-2), which can act as a strong antioxidant. 6 Therefore, the sesamin and episesamin metabolites might be involved in antioxidative activity. The roles of the endogenously generated reactive oxygen species (ROS) in the reduction and oxidation (redox) status are closely related to oxidative stress and various diseases. been shown to have good signal responses to the nitroxyl radicals, such as 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl (TEMPOL), which is used as a redox probe. A surface-coil-type resonator (SCR) that is mechanically flexible was first developed by Hirata et al. 15 We previously fabricated three types of SCRs and performed temporal ESR measurements at several sites in rats (liver, kidney, stomach, rectum, vein, and skin) following the injection of TEMPOL. 16 Results of our studies have suggested that the SCR method may be useful in the direct evaluation of the in vivo redox status in localized organs. 16, 17 Although we observed that ascorbic acid (AsA), which can directly reduce TEMPOL, could enhance TEMPOL reductions in the rat liver in vivo, we additionally found that intravenous administration of AsA oxidase led to a decrease. 18 Moreover, even though reduced glutathione (GSH) did not directly reduce TEMPOL in vitro, GSH administration did increase the in vivo hepatic reducing ability of TEMPOL. 18 In addition, we have further confirmed that GSH can recycle AsA from dehydroascorbic acid (dehydro-AsA) and suppress AsA consumption in vivo. When taken together, these findings indicate that AsA and AsA recycling from dehydro-AsA may play a crucial role in the reduction of TEMPOL via the electron transfer systems in the hepatic organelles and cell membranes. In the latest study, Yoshida et al. has found that the renal reducing ability of rats orally administered lycopene was significantly shorter than that observed in the controls. 19 This was the first report to verify in vivo antioxidant enhancement via dietary lycopene. Overall, these previous findings suggest that measurements of the redox status via use of the reducing ability of TEMPOL as the parameter for determining the antioxidant agents may be helpful in better understanding the antioxidative mechanisms of sesamin in living bodies.
The aim of the present study was to identify the antioxidative effects of sesamin in living bodies through the in vivo ESR technique that utilizes SCR measurements. In order to investigate where sesamin is active, we first examined the effects of a single oral administration of sesamin on the TEMPOL reducing ability in the liver, kidney, and inferior vena cava. Next, we focused on the effects of sesamin in the liver and carried out comparative studies between TEMPOL reductions and changes in hepatic enzymes by performing ex vivo and in vitro experiments.
Experimental

Reagents
An experimental sample of sesamin (sesamin:episesamin = 51.1:48.2, w/w) was prepared from refined sesame seed oil and purified as previously described. 1 TEMPOL was purchased from Sigma-Aldrich Chem. Co. (St. Louis, MO) and dissolved in physiological saline (Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan) at a concentration of 200 mM. All other reagents were of the highest commercially available purity.
Animals and treatments
The care and treatment of the animals conformed to the guidelines established by the Japanese Society of Nutrition and Food Science (Law No. 105 and Notification No. 6 of the Japanese government). Male Wistar rats (8 -10 weeks old), weighing about 300 g were purchased from Clea Japan Inc. (Tokyo, Japan). The animals were housed in a room at 23.5 ± 2 C, and maintained on a 12-h light-dark cycle. The rats were given a commercial diet (CE-2, Clea Japan Inc.) and had free access to water. Sesamin (250 mg/kg rat body weight) was orally administered as a suspension in olive oil at 3 or 24 h before the in vivo ESR measurements. Alpha-tocopherol was dissolved in olive oil (10 mg/kg rat body weight) and orally administered 3 h before the ESR measurements. Control animals were given the vehicle alone. All of the administrations were given as a single dose each day.
A radiofrequency ESR spectrometer
A 700 MHz microwave ESR spectrometer was constructed in our laboratory, as previously described in detail. [16] [17] [18] The SCR consisted of a single-turn coil (f = 10 mm) and transmission lines that were formed by the flexible coaxial cables. 15 The SCR was connected to the microwave circuit through a three-stub tuner and driven at a resonant frequency of approximately 720 MHz.
In vivo ESR measurements
The in vivo ESR measurements were carried out at 3 h after a single oral administration of sesamin (250 mg/kg). Rats were fasted overnight (16 h), anesthetized with pentobarbital, and then underwent laparotomy with endotracheal intubation. The single-turn coil of the SCR was placed at the surface of the target organ (liver, kidney, or inferior vena cava) in a static magnetic field at 37 C. TEMPOL (200 mM, 0.5 ml/rat weighing 300 g/shot) was injected via a tail vein. TEMPOL injections were repeated 5 times at 5-min intervals. ESR signals of TEMPOL were successively observed in the liver, kidney, and inferior vena cava of the rats after injection. When peak-to-peak line width of the ESR signal of TEMPOL exhibits no temporal changes in a target organ, the peak-to-peak height can then be used as the signal intensity. [16] [17] [18] [19] [20] In the target organs, changes in the signal intensity correspond to changes in the TEMPOL concentration. When there is good linearity in a semi-logarithmic plot of the signal intensity with high reproducibility after a TEMPOL injection, this is indicative of the pseudo-first-order kinetics of the TEMPOL decrease in the target organ. Yokoyama et al. proposed that estimations of the reducing ability of nitroxyl radicals could be calculated by using an equation that expresses the nitroxyl radical concentration in the target organ. 19, 20 The target organ (Xn) as a function of time (t) approximates Xn = Xn 0 exp (-k0nt), where Xn 0 is the initial value of the concentration and k0n is the first-order rate constant (equal to log 2/half-life). The half-lives of TEMPOL in the target organs were used as the parameter to estimate the decay rate of TEMPOL, as this parameter was not influenced by reduction in the other organs. 17, 18 After the TEMPOL injection, the half-lives were calculated using the linear regression from the initial phase of the semi-logarithmic plots of the signal intensity against time.
Ex vivo measurements of hepatic enzyme activities
Under anesthesia, the livers of sesamin-treated rats (250 mg/kg, single oral administration) were perfused with 0.9% saline and then removed. The livers were homogenized in 250 mM sucrose and 50 mM Tris (pH 7.4) with a Teflon-glass homogenizer. The microsomal fractions were separated by ultracentrifugation, with the pellet then re-suspended in homogenate buffer (pH 7.4). 21 All steps were performed at 4 C. The protein concentration was determined by the Micro BCA Protein Assay Reagent kit (Pierce, Rockford, IL). 22 All samples were stored at -80 C until use.
Microsomal NADPH-cytochrome p-450 reductase activity was assayed spectrophotometrically as NADPH-cytochrome c reductase. 23 The DT-diaphorase activity in liver homogenates was determined by following the dicumarol-insensitive reduction of cytochrome c by menadione at 550 nm. 24 GSH reductase activity was determined by following the change in absorbance that occurred when NADPH was oxidized to NADP + . 25 
In vitro measurements of TEMPOL reductions by various hepatic enzymes
The reductions of TEMPOL by a hepatic enzyme such as cytochrome p-450, cytochrome p-450 reductase, catalase, GSH peroxidase, GSHs-transferase, GSH reductase, or DT-diaphorase were determined. A total of 1 mL of 0.05 mM TEMPOL was mixed with 100 μL of the hepatic enzyme and 100 μL of NADPH or GSH as the electron donor (final concentration, 1 mM). Each mixture of TEMPOL was incubated at 37 C for 10 min. Changes in the ESR signal of TEMPOL were measured by the X-band ESR spectrometer (JES-FR30, JEOL Ltd., Tokyo, Japan). TEMPOL reduction rates were calculated as the initial rate of molecules reduced min -1 mg-protein -1 .
Statistical analysis
All data are presented as the mean ± standard error (SEM). For the half-life results, statistical analyses were evaluated using repeated measures ANOVA. When significant differences were observed, individual time points were further analyzed post hoc through the use of either a Student's t-test (comparison of two parameters). All analyses were performed using SPSS Advanced Models Version 10.0 j (SPSS Inc., Chicago, IL). Differences were considered to be significant when the probability value was less than 0.05. Figure 2 shows typical semi-logarithmic plots of the ESR signal intensities against time after the first injection of TEMPOL. TEMPOL, which is in the nitroxyl group (>N-O·), appears to be quickly converted into hydroxylamine (>N-OH) and a non-paramagnetic compound through one-electron reductions and other reactions that occur within biological systems. 26, 27 In our study, we found there was a rapid decrease of the signal intensity of TEMPOL after the reduction of TEMPOL to hydroxylamine. We confirmed that the decay rate of TEMPOL follows pseudo-first-order kinetics, meaning that the initial phase of the semi-logarithmic plots of the signal intensity against time will give a straight line (R > 0.995).
Results
To investigate the effects of sesamin on the elimination of TEMPOL, we examined the ESR spectra detected at 3 h after the oral administration of sesamin (250 mg/kg). As shown in Fig. 3 , a statistically significant difference was noted for the half-lives in the liver of the sesamin-treated rats, with values that were 10 -15% shorter than those found for the control group. However, in the kidney and the inferior vena cava, sesamin had no effect on the TEMPOL reduction. Enhancements of the hepatic reducing abilities in the sesamin-treated rats were maintained for 3 h after a single oral administration, and then disappeared at 24 h (Table 1) .
Our current study evaluated whether or not several hepatic enzymes could reduce TEMPOL in vitro. As seen in Fig. 4 , NADPH-cytochrome p-450 reductase, GSH reductase and DT-diaphorase with suitable electron donors all proved to be effective in eliminating TEMPOL in vitro. Table 2 shows the catalytic activities of the hepatic enzymes in the liver of the sesamin-treated rats. At 3 h after the single oral administration of sesamin (250 mg/kg), the NADPH-cytochrome p-450 reductase, GSH reductase and DT-diaphorase activities in the liver of rats were not affected. Figure 5 shows the ESR spectra detected in the liver at 3 h Fig. 2 Examples of the semi-logarithmic plot of the ESR signal intensity of TEMPOL in the liver ( ), kidney ( ) and inferior vena cava ( ) against time. TEMPOL (200 mM, 0.5 ml/rats weighing 300 g/shot) was injected via the tail vein. Fig. 3 Half-lives of TEMPOL in the liver (A), kidney (B) and inferior vena cava (C) after TEMPOL injection. At 3 h after the oral administration of sesamin, there was detection of the ESR spectra. TEMPOL (200 mM, 0.5 ml/rats weighing 300 g/shot) was injected via the tail vein, with the injection of TEMPOL repeated five times at 5 min intervals. The values are means ± SEM (n = 5 -6). Significant difference from the control group: *, p < 0.05; **, p < 0.01.
after the single administration of alpha-tocopherol (10 mg/kg). Both the 4th and 5th half-lives of alpha-tocopherol-treated rats were found to be significantly shorter than those observed in the controls.
Discussion
In this study, we used the half-life to compare the reductions that occurred after the injection of TEMPOL via the tail vein. After the first injection of TEMPOL, the half-lives observed in the liver, kidney, and inferior vena cava were 32.6 ± 0.9, 19.5 ± 0.6, and 76.6 ± 0.5 s (means ± SEM, n = 5 -6), respectively (Fig. 3) . The TEMPOL half-lives in the liver and kidney were much shorter than those in the vena cava, which was most likely due to equilibrium with the peripheral tissues. Our previous studies have found that various organs have considerably different reducing abilities of TEMPOL, with the kidney half-life the shortest of all of the organs evaluated.
17,19
Since it is well-known that exogenous nitroxyl radicals are reduced and excreted from the kidney, 28 we evaluated the excretion of TEMPOL into the urine. Urine was collected from the bladder 1 and 5 min after a tail vein injection of TEMPOL and then measured by the X-band ESR with and without ferricyanide oxidization. 17 No ESR signals were observed at 1 and 5 min after the intravenous injection without ferricyanide oxidization. After oxidative treatment by ferricyanide, ESR signals were observed slightly 5 min after injection (approximately 2.4% per concentration of TEMPOL injected), demonstrating the existence of hydroxylamine. This finding indicates that there was little urinary excretion of TEMPOL during our in vivo ESR measurement period. 17 We confirmed that the excretion of TEMPOL and its hydroxylamine into the bile were approximately 0.2 and 4.0%, respectively, during the 10 min after the intravenous injection of TEMPOL. These findings suggest that the excretion of TEMPOL into the urine and bile has a negligible effect on the half-life of TEMPOL, with the diminution of TEMPOL directly due to the reduction that occurs in the target organ. As a consequence, there was a The TEMPOL half-lives were caluculated from the decay rate of the ESR signal intensity after each TEMPOL injection. Values are means ± SEM (3-h groups; n = 5 -6, 24-h groups; n = 4). Significantly defferent from control, *, p < 0.05; **, p < 0.01 (Student's t-test). Fig. 4 Effects of various hepatic enzymes on the reduction of TEMPOL in vitro. Reduction rate of 0.05 mM TEMPOL in the presence of 1 mM NADPH or 1 mM GSH was measured by the X-band ESR system, with the data described as the initial rate of the molecules reduced min -1 mg-protein -1 . Fig. 5 Half-lives of TEMPOL in the liver after TEMPOL injection under the same conditions used in Fig. 3 . At 3 h after oral administration of alpha-tocopherol, there was detection of the ESR spectra. The values are means ± SEM (n = 5 -6). Significant difference from the control group: *, p < 0.05.
gradual slowing of the elimination speeds of TEMPOL after the repeated injections due to consumption of the spontaneous reducing agents of TEMPOL. During our examination of the elimination of TEMPOL, we discovered that an oral administration of sesamin markedly enhanced the reducing ability of TEMPOL only in the hepatic sites, as compared to the controls. There were no significant changes noted for either the kidney or the inferior vena cava. It has been reported that the administration of sesamin suppressed the levels of lipid peroxide in the liver and plasma in several animal models and in humans. [3] [4] [5] 7 The results of our in vivo ESR measurements may provide redox information on intracellular function. Moreover, our study is the first to successfully provide real time observations of the antioxidative action by sesamin in the liver of living bodies.
Previous studies have reported that sesamin was absorbed via the portal vein in its native form, metabolized to the compounds with dihydroxyphenyl groups (SC-1 and SC-2) by enzymes in the hepatocytes, and then finally excreted in the bile and urine as conjugates. 6 After the introduction of a 1% sesamin-containing diet, the plasma concentration of sesamin, SC-1, and SC-2 were 0.2 ±0.1, 12.7 ± 0.9, and 3.0 ± 0.1 μM, respectively, indicating the major metabolite after sesamin administration was SC-1. In our preliminary pharmacokinetic studies, we confirmed that sesamin and its metabolite were detected in the liver during the 3-to 7-h period after a single oral administration and then eliminated during the following 24 h (unpublished data). This suggests that there is a specific effective period of the enhancement for the TEMPOL reduction. Although sesamin does not have a phenolic hydroxyl group and has little radical-scavenging activity, the metabolites with dihydroxyphenyl groups (SC-1 and SC-2) have been shown to display potent radical-scavenging activities in vitro. 6, 11 Therefore, it is possible that sesamin metabolites may exert an antioxidative effect in the liver.
Our previous studies have also demonstrated that TEMPOL was metabolized by cytosol, mitochondria, and microsomes via enzymatic or non-enzymatic systems in vivo. 18, [29] [30] [31] [32] [33] To clarify the TEMPOL reduction by the enzymatic systems, we examined the influence of several hepatic enzymes on the TEMPOL reduction. After determining that NADPH-cytochrome p-450 reductase, GSH reductase and DT-diaphorase were all effective in TEMPOL reduction in vitro, we then evaluated the effects of sesamin on the activity of the hepatic enzymes ex vivo under the same conditions used for the in vivo ESR studies. Our results showed that the activities of NADPH-cytochrome p-450 reductase, GSH reductase, and DT-diaphorase in the liver of sesamin-treated rats were not significantly changed as compared to that observed in the controls. Thus, these findings suggested that the hepatic reducing activity might not be related to the enzyme reactions that occur within 3 h after the oral sesamin administration. Figure 6 shows the proposed relationship between the antioxidative mechanisms and the TEMPOL reductions. Previous studies have demonstrated that AsA can directly reduce TEMPOL in vitro. We further confirmed that the half-lives of TEMPOL in the liver of AsA-treated rats (single dose of AsA; 250 mg/kg rat body weight) 1 h before in vivo ESR measurements were significantly shorter than those in the control group (AsA group, 27.4 ± 1.5 s (P < 0.05) vs. control, 33.9 ± 1.7 s). 18 Additionally, as seen in Fig. 5 , administration of alpha-tocopherol improved the half-lives of TEMPOL in the liver. Matsumoto et al. 34 reported that the feeding of AsA or alpha-tocopherol containing foods to rats for 2 or 4 weeks significantly enhanced the radical reducing ability. Furthermore, GSH administration has also been reported to improve the half-lives of TEMPOL in the liver. 18 In the in vitro ESR studies, ESR measurements of the mixture of TEMPOL and GSH or alpha-tocopherol were performed immediately after mixing. Results indicated there were no significant differences in the ESR signal intensities between any of the samples. This demonstrates that GSH and alpha-tocopherol cannot directly reduce TEMPOL. We further confirmed that GSH and alpha-tocopherol were able to recycle AsA from dehydro-AsA and suppress the AsA consumption in vivo. These findings show that AsA and AsA recycling from dehydro-AsA may play a crucial role in the TEMPOL reduction via electron transfer systems in the hepatic organelles and cell membranes.
Sesamin has been reported to enhance the antioxidant activity of alpha-tocopherol in lipid peroxidation systems. 35 In another study that examined 4-week-long experimental feeding schedules, an alpha-tocopherol free diet that contained sesamin increased the AsA levels in some of the tissues in rats. 36 It has been previously shown that sesamin and its metabolites are not able to reduce TEMPOL rapidly in vitro. Based on this overall information, we proposed an antioxidative mechanism for sesamin that was correlated with the AsA and AsA recycling from the dehydro-AsA cycles. Thus, this has led to the suggestion that sesamin might function by compensating for the spontaneous AsA consumed by the repeated TEMPOL injections through recycling of the AsA from the dehydro-AsA. However, in order to be able to definitively elucidate the mechanism of the antioxidative actions by sesamin in the liver, further studies will need to be undertaken.
Although TEMPOL can be quickly reduced by AsA, TEMPOL can also be oxidized to the oxoammonium cation (>+N=O) by ·OH. 26 Thus, it is possible that the oxoammonium cation could receive hydrogen from hydrogen donors such as NADPH and GSH via the GSH reductase and be reduced to hydroxylamine. In addition, the oxoammonium cation and GSH might be able to create a redox stable complex, that is >N-O-SG. However, we found that a single oral administration of sesamin was not able to affect the level of the GSH reductase (Table 2) . Even though the sesamin metabolites can scavenge ·OH, the dose of TEMPOL was higher than that of sesamin and the rate constants for the reactions of ·OH with nitroxyl radicals were high. This suggests that the effects of sesamin on the half-life of TEMPOL in vivo might not be related to this pathway, which includes the GSH-GSH reductase cycle.
In conclusion, an incremental reducing ability of TEMPOL was only observed in the hepatic sites of sesamin-treated rats before changes in the levels of the redox enzymes. This suggests that until the sesamin disappears from the liver, it might act as a pro-antioxidant in vivo through the sesamin metabolism pathways that are linked to the hepatic cytochrome p-450. Almost all of the previous studies on the antioxidant mechanisms of sesamin have been performed during chronic sesamin administrations. [3] [4] [5] [6] [7] [8] [9] [10] Thus, the findings of our in vivo studies are the first to provide information on the special antioxidative functions that occur due to acute sesamin effects. The current results also suggest that the sesamin derivatives, such as monoand di-catechol metabolites, might be able to help with the recovery after the consumption of the endogenous AsA, GSH, and alpha-tocopherol in the liver. Real-time monitoring of the redox states in vivo may be useful for discovering new functions of foods.
